ATAI
Price
$1.15
Change
+$0.03 (+2.68%)
Updated
Dec 6, 6:59 PM EST
111 days until earnings call
TDCX
Price
$4.72
Change
-$0.13 (-2.68%)
Updated
Dec 6, 6:59 PM EST
Ad is loading...

Compare predictions ATAI vs TDCX

Header iconATAI vs TDCX Comparison
Open Charts ATAI vs TDCXBanner chart's image
ATAI Life Sciences
Price$1.15
Change+$0.03 (+2.68%)
Volume$418.41K
CapitalizationN/A
TDCX
Price$4.72
Change-$0.13 (-2.68%)
Volume$17.03K
CapitalizationN/A
View a ticker or compare two or three
ATAI vs TDCX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ATAI vs. TDCX commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and TDCX is a Hold.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (ATAI: $1.15 vs. TDCX: $4.75)
Brand notoriety: ATAI and TDCX are both not notable
ATAI represents the Biotechnology, while TDCX is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: ATAI: 100% vs. TDCX: 34%
Market capitalization -- ATAI: $179.29M vs. TDCX: $710.1M
ATAI [@Biotechnology] is valued at $179.29M. TDCX’s [@Miscellaneous Commercial Services] market capitalization is $710.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $73.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $4.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileTDCX’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • TDCX’s FA Score: 0 green, 5 red.
According to our system of comparison, TDCX is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while TDCX’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 2 bearish.
  • TDCX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than TDCX.

Price Growth

ATAI (@Biotechnology) experienced а +2.68% price change this week, while TDCX (@Miscellaneous Commercial Services) price change was -5.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.65%. For the same industry, the average monthly price growth was +5.77%, and the average quarterly price growth was +27.21%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +1.02%. For the same industry, the average monthly price growth was +3.58%, and the average quarterly price growth was +8.52%.

Reported Earning Dates

ATAI is expected to report earnings on Mar 27, 2024.

Industries' Descriptions

@Biotechnology (+6.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (+1.02% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
A.I.dvisor published
a Summary for ATAI with price predictions.
OPEN
A.I.dvisor published
a Summary for TDCX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TDCX($710M) has a higher market cap than ATAI($179M). ATAI YTD gains are higher at: -56.767 vs. TDCX (-61.632). TDCX has higher annual earnings (EBITDA): 186M vs. ATAI (-67.3M). TDCX has more cash in the bank: 491M vs. ATAI (209M). ATAI has less debt than TDCX: ATAI (16.7M) vs TDCX (34.9M). TDCX has higher revenues than ATAI: TDCX (676M) vs ATAI (334K).
ATAITDCXATAI / TDCX
Capitalization179M710M25%
EBITDA-67.3M186M-36%
Gain YTD-56.767-61.63292%
P/E RatioN/A8.42-
Revenue334K676M0%
Total Cash209M491M43%
Total Debt16.7M34.9M48%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAITDCX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PABAX14.93-0.01
-0.07%
Putnam Dynamic Asset Allocation Bal A
LCEAX17.84-0.04
-0.22%
Invesco Diversified Dividend A
MDOBX8.01-0.02
-0.25%
Morgan Stanley Developing Opportunity C
IGNIX15.84-0.07
-0.44%
Delaware Ivy Natural Resources I
HFMDX20.46-0.23
-1.11%
Hennessy Cornerstone Mid Cap 30 Inv

TDCX and

Correlation & Price change

A.I.dvisor tells us that TDCX and ARLO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDCX and ARLO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDCX
1D Price
Change %
TDCX100%
-2.46%
ARLO - TDCX
31%
Poorly correlated
-2.04%
DNB - TDCX
30%
Poorly correlated
-2.06%
LZ - TDCX
25%
Poorly correlated
-0.62%
ATAI - TDCX
25%
Poorly correlated
+2.68%
CPRT - TDCX
23%
Poorly correlated
-2.19%
More